Old Web
English
Sign In
Acemap
>
authorDetail
>
Huy Van Nguyen
Huy Van Nguyen
Alnylam Pharmaceuticals
Antithrombin
Medicine
Dosing
Immunology
Clinical trial
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran – results of the phase 1 inhibitor cohort
2021
Journal of Thrombosis and Haemostasis
K. John Pasi
Toshko Lissitchkov
Vasily Mamonov
Tim Mant
Margarita Timofeeva
Catherine Bagot
Pratima Chowdary
Pencho Georgiev
Liana Gercheva-Kyuchukova
Kate Madigan
Huy Van Nguyen
Qifeng Yu
Baisong Mei
Craig Benson
Margaret V. Ragni
Show All
Source
Cite
Save
Citations (4)
The Role of Antithrombin Lowering in Patients with Hemophilia: Hemostatic Control Pre- and Post-Fitusiran Dosing Interruption
2018
Blood
Margaret V. Ragni
Pencho Georgiev
Michael Desmond Creagh
Toshko Lissitchkov
Steve K Austin
Charles R. M. Hay
Inga Hegemann
Syed Rashid Saeed Kazmi
Pratima Chowdary
Savita Rangarajan
Meredith C. Foster
Qifeng Yu
Craig Benson
Kate Madigan
Huy Van Nguyen
Shariq Ali
Ketaki Kadam
Pallavi Jain
K. John Pasi
Show All
Source
Cite
Save
Citations (1)
Perioperative Management in Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia
2017
Blood
Claude Negrier
Margaret V. Ragni
Pencho Georgiev
Toshko Lissitchkov
Huy Van Nguyen
Kate Madigan
K. John Pasi
Show All
Source
Cite
Save
Citations (5)
1